Adult T-cell leukemia/lymphoma: A pending challenge

Alvarez C.; Beltrán B. · Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo (2023) · DOI: 10.35434/rcmhnaaa.2023.164.2189

Resumen

Adult T-cell leukemia/lymphoma (ATLL) is a post timic T-cell neoplasia of poor prognosis and difficult management. It has been etiologically associated with Human T-lymphotropic virus 1 (HTLV-1), a retrovirus that has been identified in endemic regions such as Japan, Western Africa, the Caribbean islands and South America. In Perú, it is estimated that 1-2% of the population carries the virus. The lifetime risk for an HTLV-1 carrier to develop ATLL is 5%. Given the endemicity of this infection in our setting and the poor overall prognosis of ATLL, there is a need for novel therapeutic strategies and preventive interventions. In this review, we explore the clinical and epidemiological characteristics of ATLL and its therapeutic options.

Instituciones: Universidad Peruana Cayetano Heredia; Universidad Ricardo Palma